We are live on ! Find out more
IART icon

Integra LifeSciences
IART

249 hedge funds and large institutions have $4.87B invested in Integra LifeSciences in 2018 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 84 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 84

14% more call options, than puts

Call options by funds: $7.57M | Put options by funds: $6.64M

4.26% more ownership

Funds ownership: 82.58% → 86.85% (+4.3%)

4% more capital invested

Capital invested by funds: $4.67B → $4.87B (+$195M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 257 → 249 (-8)

10% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 40

Holders
249
Holders Change
-8
Holders Change %
-3.11%
% of All Funds
5.69%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
36
Increased
96
Reduced
84
Closed
40
Calls
$7.57M
Puts
$6.64M
Net Calls
+$933K
Net Calls Change
-$658K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$87.4M
2
Capital World Investors
Capital World Investors
California
+$57.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$35.6M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$26.3M
5
First Trust Advisors
First Trust Advisors
Illinois
+$20M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$46.5M
2
Wells Fargo
Wells Fargo
California
-$33.5M
3
GT
Glenmede Trust
Pennsylvania
-$26.3M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$20.6M
5
Millennium Management
Millennium Management
New York
-$19.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCIA
176
Campbell & Co Investment Adviser
Maryland
$371K +$350K +5,635 New
ECM
177
ETrade Capital Management
Virginia
$364K +$9.32K +150 +3%
VIM
178
Vista Investment Management
Pennsylvania
$339K – – –
QSS
179
Quantitative Systematic Strategies
Florida
$337K -$684 -11 -0.2%
SCM
180
Shelton Capital Management
Colorado
$333K +$314K +5,052 New
CCA
181
Conestoga Capital Advisors
Pennsylvania
$329K – – –
HSBC Holdings
182
HSBC Holdings
United Kingdom
$327K -$1.07M -17,194 -78%
IG
183
ING Group
Netherlands
$323K +$305K +4,902 New
BC
184
Burney Company
Virginia
$307K -$11.8K -190 -4%
Zurich Cantonal Bank
185
Zurich Cantonal Bank
Switzerland
$307K +$19.3K +310 +7%
RCM
186
Riverhead Capital Management
Delaware
$305K +$74.6K +1,200 +35%
AIC
187
Argus Investors Counsel
New York
$300K +$283K +4,547 New
JMPWA
188
JP Morgan Private Wealth Advisors
California
$281K -$32.5K -523 -11%
LCM
189
Landscape Capital Management
New Jersey
$277K +$262K +4,212 New
LIA
190
LS Investment Advisors
Michigan
$273K -$8.45K -136 -3%
LP
191
LMR Partners
United Kingdom
$272K -$4.86M -78,208 -95%
ZB
192
Zions Bancorporation
Utah
$272K +$257K +4,130 New
WAM
193
World Asset Management
Michigan
$268K +$559 +9 +0.2%
SLG
194
Stanley-Laman Group
Pennsylvania
$263K – – –
PIA
195
Piedmont Investment Advisors
North Carolina
$262K +$247K +3,967 +66,117%
CCM
196
Coldstream Capital Management
Washington
$261K +$6.96K +112 +3%
PTC
197
Petrus Trust Company
Texas
$248K +$234K +3,760 New
WT
198
Whittier Trust
California
$220K – – –
MOS
199
MGO One Seven
Ohio
$211K +$200K +3,218 New
Koshinski Asset Management
200
Koshinski Asset Management
Illinois
$201K +$190K +3,050 New
6 7
8
9 10

IART Hedge Fund Activity: Q3 2018 in Review

249 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2018, worth a combined $4.87B — up 4.2% from $4.67B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of IART and 36 opened new positions — a net loss of 4 holders — while 84 trimmed existing stakes and 96 added.

The largest buyer was Wellington Management Group, adding an estimated $87.4M. The largest seller was Goldman Sachs, cutting an estimated $46.5M.

  • 249 institutional investors held Integra LifeSciences (IART) as of Q3 2018, down from 257 in Q2 2018.
  • Funds reported $4.87B of Integra LifeSciences stock for Q3 2018, up 4.2% quarter-over-quarter.
  • 36 funds opened new Integra LifeSciences positions in Q3 2018 and 40 closed out, a net change of -4 holders.
  • The largest Integra LifeSciences buyer in Q3 2018 was Wellington Management Group, an estimated $87.4M added.
  • The largest Integra LifeSciences seller in Q3 2018 was Goldman Sachs, an estimated $46.5M sold.

Based on aggregated 13F filings for Q3 2018.